Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.

Ström, O

Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Apr 2013 - 1491-502 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1433-2965

10.1007/s00198-012-2115-6 doi


Aged
Aged, 80 and over
Alendronate--economics
Algorithms
Antibodies, Monoclonal, Humanized--economics
Bone Density Conservation Agents--economics
Cost-Benefit Analysis
Denosumab
Drug Costs--statistics & numerical data
Etidronic Acid--analogs & derivatives
Female
Health Care Costs--statistics & numerical data
Humans
Middle Aged
Models, Econometric
Osteoporosis, Postmenopausal--drug therapy
Osteoporotic Fractures--economics
Quality of Life
RANK Ligand--antagonists & inhibitors
Risedronic Acid
Risk Assessment--methods
Thiophenes--economics
United Kingdom--epidemiology